PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 18.05 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2023-03-30
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-12-31 was 0.00 shares.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 18.05M shares, a 129.83% increase from fiscal 2020.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2020 was 7.86M shares, a 55.67% increase from fiscal 2019.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2019 was 5.05M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 18.05M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 18.05M shares 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | 7.86M shares 10-K · filed 2022-03-29 | ||
| 2019-12-31 | 5.05M shares 10-K · filed 2021-03-02 |